Literature DB >> 25616962

FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.

Matthew R Karolak1, Xiangli Yang2, Florent Elefteriou3.   

Abstract

Aberrant fibroblast growth factor receptor 3 (FGFR3) signaling disrupts chondrocyte proliferation and growth plate size and architecture, leading to various chondrodysplasias or bone overgrowth. These observations suggest that the duration, intensity and cellular context of FGFR signaling during growth plate chondrocyte maturation require tight, regulated control for proper bone elongation. However, the machinery fine-tuning FGFR signaling in chondrocytes is incompletely defined. We report here that neurofibromin, a Ras-GAP encoded by Nf1, has an overlapping expression pattern with FGFR1 and FGFR3 in prehypertrophic chondrocytes, and with FGFR1 in hypertrophic chondrocytes during endochondral ossification. Based on previous evidence that neurofibromin inhibits Ras-ERK signaling in chondrocytes and phenotypic analogies between mice with constitutive FGFR1 activation and Nf1 deficiency in Col2a1-positive chondrocytes, we asked whether neurofibromin is required to control FGFR1-Ras-ERK signaling in maturing chondrocytes in vivo. Genetic Nf1 ablation in Fgfr1-deficient chondrocytes reactivated Ras-ERK1/2 signaling in hypertrophic chondrocytes and reversed the expansion of the hypertrophic zone observed in mice lacking Fgfr1 in Col2a1-positive chondrocytes. Histomorphometric and gene expression analyses suggested that neurofibromin, by inhibiting Rankl expression, attenuates pro-osteoclastogenic FGFR1 signaling in hypertrophic chondrocytes. We also provide evidence suggesting that neurofibromin in prehypertrophic chondrocytes, downstream of FGFRs and via an indirect mechanism, is required for normal extension and organization of proliferative columns. Collectively, this study indicates that FGFR signaling provides an important input into the Ras-Raf-MEK-ERK1/2 signaling axis in chondrocytes, and that this input is differentially regulated during chondrocyte maturation by a complex intracellular machinery, of which neurofibromin is a critical component.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25616962      PMCID: PMC4383864          DOI: 10.1093/hmg/ddv019

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  62 in total

1.  Genetic inactivation of ERK1 and ERK2 in chondrocytes promotes bone growth and enlarges the spinal canal.

Authors:  Arjun Sebastian; Takehiko Matsushita; Aya Kawanami; Susan Mackem; Gary E Landreth; Shunichi Murakami
Journal:  J Orthop Res       Date:  2010-10-04       Impact factor: 3.494

2.  Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.

Authors:  Weixi Wang; Jeffry S Nyman; Koichiro Ono; David A Stevenson; Xiangli Yang; Florent Elefteriou
Journal:  Hum Mol Genet       Date:  2011-07-14       Impact factor: 6.150

Review 3.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 4.  Vertebrate skeletogenesis.

Authors:  Véronique Lefebvre; Pallavi Bhattaram
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

5.  Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter.

Authors:  Sonja Gebhard; Takako Hattori; Eva Bauer; Britta Schlund; Michael R Bösl; Benoit de Crombrugghe; Klaus von der Mark
Journal:  Matrix Biol       Date:  2008-07-12       Impact factor: 11.583

Review 6.  Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options.

Authors:  Florent Elefteriou; Mateusz Kolanczyk; Aaron Schindeler; David H Viskochil; Janet M Hock; Elizabeth K Schorry; Alvin H Crawford; Jan M Friedman; David Little; Juha Peltonen; John C Carey; David Feldman; Xijie Yu; Linlea Armstrong; Patricia Birch; David L Kendler; Stefan Mundlos; Feng-Chun Yang; Gina Agiostratidou; Kim Hunter-Schaedle; David A Stevenson
Journal:  Am J Med Genet A       Date:  2009-10       Impact factor: 2.802

7.  A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes.

Authors:  Sylvain Provot; Gregory Nachtrab; Jennifer Paruch; Adele Pin Chen; Alcino Silva; Henry M Kronenberg
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

8.  Cellular and molecular bases of skeletal regeneration: what can we learn from genetic mouse models?

Authors:  Rana Abou-Khalil; Céline Colnot
Journal:  Bone       Date:  2014-04-04       Impact factor: 4.398

9.  Matrix-embedded cells control osteoclast formation.

Authors:  Jinhu Xiong; Melda Onal; Robert L Jilka; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien
Journal:  Nat Med       Date:  2011-09-11       Impact factor: 53.440

10.  Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.

Authors:  Jean de la Croix Ndong; Alexander J Makowski; Sasidhar Uppuganti; Guillaume Vignaux; Koichiro Ono; Daniel S Perrien; Simon Joubert; Serena R Baglio; Donatella Granchi; David A Stevenson; Jonathan J Rios; Jeffry S Nyman; Florent Elefteriou
Journal:  Nat Med       Date:  2014-07-06       Impact factor: 53.440

View more
  9 in total

1.  FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.

Authors:  Kannan Karuppaiah; Kai Yu; Joohyun Lim; Jianquan Chen; Craig Smith; Fanxin Long; David M Ornitz
Journal:  Development       Date:  2016-04-06       Impact factor: 6.868

Review 2.  Fibroblast growth factor signalling in osteoarthritis and cartilage repair.

Authors:  Yangli Xie; Allen Zinkle; Lin Chen; Moosa Mohammadi
Journal:  Nat Rev Rheumatol       Date:  2020-08-17       Impact factor: 20.543

3.  The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.

Authors:  S E Tahaei; G Couasnay; Y Ma; N Paria; J Gu; B F Lemoine; X Wang; J J Rios; F Elefteriou
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

Review 4.  Emerging therapeutic targets for neurofibromatosis type 1.

Authors:  James A Walker; Meena Upadhyaya
Journal:  Expert Opin Ther Targets       Date:  2018-05-07       Impact factor: 6.902

Review 5.  Fibroblast growth factor signaling in skeletal development and disease.

Authors:  David M Ornitz; Pierre J Marie
Journal:  Genes Dev       Date:  2015-07-15       Impact factor: 11.361

6.  Screening for potential genes associated with bone overgrowth after mid-shaft femur fracture in a rat model.

Authors:  Chibing Liu; Yanting Liu; Weizhong Zhang; Xiuxin Liu
Journal:  J Orthop Surg Res       Date:  2017-01-17       Impact factor: 2.359

Review 7.  The Evolution of Biomineralization through the Co-Option of Organic Scaffold Forming Networks.

Authors:  Smadar Ben-Tabou de-Leon
Journal:  Cells       Date:  2022-02-09       Impact factor: 6.600

Review 8.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

9.  SHP2 Regulates the Osteogenic Fate of Growth Plate Hypertrophic Chondrocytes.

Authors:  Lijun Wang; Jiahui Huang; Douglas C Moore; Chunlin Zuo; Qian Wu; Liqin Xie; Klaus von der Mark; Xin Yuan; Di Chen; Matthew L Warman; Michael G Ehrlich; Wentian Yang
Journal:  Sci Rep       Date:  2017-10-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.